These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28914173)

  • 1. Flow cytometric analysis of patients with hereditary spherocytosis - an Indian scenario.
    Manivannan P; Tyagi S; Chandra D; Mishra P; Pati HP; Saxena R
    Hematology; 2018 Apr; 23(3):175-180. PubMed ID: 28914173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric osmotic fragility testing does reflect the clinical severity of hereditary spherocytosis.
    Shim YJ; Won DI
    Cytometry B Clin Cytom; 2014 Nov; 86(6):436-43. PubMed ID: 24243866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
    Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric osmotic fragility test: Increased assay sensitivity for clinical application in pediatric hematology.
    Ciepiela O; Adamowicz-Salach A; Zgodzińska A; Łazowska M; Kotuła I
    Cytometry B Clin Cytom; 2018 Jan; 94(1):189-195. PubMed ID: 28103644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow Cytometric Analysis of Erythrocytes Osmotic Fragility in Hereditary Spherocytosis: A Case-Controlled Study Evaluating the Best Anticoagulant, Sample Pre-Treatment and NaCl Concentration for Reliable Screening of this Red Blood Cell Membrane Disorder.
    Nobre CS; Silva JA; Jácomo RH; Nery LFA; Barra GB
    Cytometry B Clin Cytom; 2018 Nov; 94(6):910-917. PubMed ID: 30328264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
    Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
    Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Flow-Cytometric Osmotic Fragility Test for Hereditary Spherocytosis in Chinese Patients.
    Tao YF; Deng ZF; Liao L; Qiu YL; Deng XL; Chen WQ; Lin FQ
    Acta Haematol; 2016; 135(2):88-93. PubMed ID: 26505491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
    Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
    Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis.
    Shahal-Zimra Y; Nosgorodcky Y; Eshel E; Rotem Z; Ross L; Pickholtz I; Rabizadeh E; Chezar J
    Cytometry B Clin Cytom; 2022 Sep; 102(5):377-383. PubMed ID: 34528390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric osmotic fragility--an effective screening approach for red cell membranopathies.
    Warang P; Gupta M; Kedar P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2011 May; 80(3):186-90. PubMed ID: 21298775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in laboratory diagnosis of hereditary spherocytosis.
    Farias MG
    Clin Chem Lab Med; 2017 Jun; 55(7):944-948. PubMed ID: 27837594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Kotwal J; Bhargava M
    Hematology; 2018 Aug; 23(7):413-416. PubMed ID: 29338606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients.
    Tao YF; Deng ZF; Liao L; Qiu YL; Chen WQ; Lin FQ
    Ann Hematol; 2015 May; 94(5):747-51. PubMed ID: 25501660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of cryohemolysis test in the diagnosis of hereditary spherocytosis.
    Romero RR; Poo JL; Robles JA; Uriostegui A; Vargas F; Majluf-Cruz A
    Arch Med Res; 1997; 28(2):247-51. PubMed ID: 9204617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis.
    Broséus J; Visomblain B; Guy J; Maynadié M; Girodon F
    Int J Lab Hematol; 2010 Oct; 32(5):519-23. PubMed ID: 20136849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric detection of erythrocyte osmotic fragility.
    Won DI; Suh JS
    Cytometry B Clin Cytom; 2009 Mar; 76(2):135-41. PubMed ID: 18727072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage of hyperdense cells: Automated parameter to hereditary spherocytosis screening.
    Farias MG; Freitas PA
    Clin Biochem; 2015 Dec; 48(18):1341-3. PubMed ID: 26210847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina.
    Crisp RL; Solari L; Vota D; García E; Miguez G; Chamorro ME; Schvartzman GA; Alfonso G; Gammella D; Caldarola S; Riccheri C; Vittori D; Venegas B; Nesse A; Donato H
    Ann Hematol; 2011 Jun; 90(6):625-34. PubMed ID: 21080168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
    Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
    Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India.
    Kar R; Rao S; Srinivas UM; Mishra P; Pati HP
    Hematology; 2009 Jun; 14(3):164-7. PubMed ID: 19490762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.